Showing results (681-690 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|July 8, 2025
IgE-mediated anaphylaxis induced by pembrolizumabRomane Legroux, Jeanne-Marie Perotin, Gabrielle Wintrebert, et al.Immunotherapy|April 2, 2025
Late-onset recurrent immune checkpoint inhibitor-related pneumonitis after cessation of pembrolizumab: a case reportBahadır Köylü, Cevat İlteriş Kıkılı, Öner Dikensoy, et al.Immunotherapy|May 12, 2025
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer modelAtefeh Yari, Seyed Younes Hosseini, Sanaz Asiyabi, et al.Immunotherapy|May 8, 2025
Arthralgia in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysisYoshito Nishimura, Jonathan Estaris, Mako Koseki, et al.Immunotherapy|August 9, 2025
Pitfalls and strategies of CAR-T therapy in solid tumors and implications for chordoma treatmentM Qi, G Cattaneo, C Camillo, et al.Immunotherapy|August 11, 2025
Evaluating rilzabrutinib in the treatment of immune thrombocytopeniaDavid J Kuter, Waleed GhanimaImmunotherapy|October 17, 2025
How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?Arvind Suresh, Darren Pan, Jodi Lipof, et al.Immunotherapy|October 23, 2025
The potential of CAR T cells in autoimmune diseasesJohanna Richter, Martin Krusche, Isabell Haase, et al.Immunotherapy|October 17, 2025
5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLCStephen V Liu, Riddhi A Babel, Yu-Han Kao, et al.Immunotherapy|October 14, 2025
Recombinant GM-CSF drug evaluation reviewJack McCarthy, Niamh Boyle, Cormac McCarthyPageof 188